Literature DB >> 8613489

B-cell superantigens: definition and potential impact on the immune response.

A I Levinson1, L Kozlowski, Y Zheng, L Wheatley.   

Abstract

Superantigens have been extremely helpful tools in exploring fundamental questions in immunobiology including mechanisms of cell activation, tolerance, and autoimmunity. Until recently, attention has been focused exclusive on T-cell superantigens. However, new data suggest that there are superantigens that directly activate B cells. By definition, these agents (1) stimulate a high frequency of B cells, (2) target B cells that have restricted usage of VH or VL family genes, and (3) bind to immunoglobulins outside the sites that bind conventional antigens. A candidate B-cell superantigen that has received considerable attention in this laboratory is staphylococcal protein A. This agent is best known to the immunologist because of its ability to bind to the Fc fragment of IgG. This binding has been localized to two alpha-helical structures on each of four or five homologous regions that comprise the extracellular domain of protein A. However, it is now clear that protein A contains a second site that binds to determinants on the Fab regions of certain immunoglobulins independently of their heavy-chain isotype. In man this so-called alternative site appears to bind only to immunoglobulins that utilize heavy-chain genes of the VH3 subfamily. In the mouse this type of binding is restricted to immunoglobulins using heavy chains belonging to the S107 and J606 VH families. In this review, we examine the growing list of microbial products that dominate B-cell superantigenic properties. Using staphylococcal protein A as a model for a B-cell superantigen, we consider the potential impact of this novel class of antigens on the immune response. We focus on the ability of B-cell superantigens to influence the expression of the B-cell repertoire. In addition, we consider the hypothesis that the interaction of a B-cell superantigen with its reactive serum immunoglobulins activates the classical complement cascade and thus represents a powerful stimulant of tissue inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8613489     DOI: 10.1007/bf01540891

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  13 in total

1.  Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma.

Authors:  R Marasca; P Vaccari; M Luppi; P Zucchini; I Castelli; P Barozzi; A Cuoghi; G Torelli
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  The B-cell superantigen Finegoldia magna protein L causes pulmonary inflammation by a mechanism dependent on MyD88 but not B cells or immunoglobulins.

Authors:  Amy L Anderson; Yi Zheng; Decheng Song; David Larosa; Nico Van Rooijen; Gerold Kierstein; Sonja Kierstein; Angela Haczku; Arnold I Levinson
Journal:  Inflamm Res       Date:  2012-01-17       Impact factor: 4.575

3.  Children with atopic dermatitis who carry toxin-positive Staphylococcus aureus strains have an expansion of blood CD5- B lymphocytes without an increase in disease severity.

Authors:  P D Arkwright; B D Cookson; M R Haeney; D Sanyal; M R Potter; T J David
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

4.  Pathogenesis of B-cell superantigen-induced immune complex-mediated inflammation.

Authors:  Amy L Anderson; Romeo Sporici; John Lambris; David Larosa; Arnold I Levinson
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody Superantigen.

Authors:  Chinh Tran-To Su; Wai-Heng Lua; Jun-Jie Poh; Wei-Li Ling; Joshua Yi Yeo; Samuel Ken-En Gan
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

6.  Biased use of the IGHV4 family and evidence for antigen selection in Chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas.

Authors:  Daxing Zhu; Chen Lossos; Jennifer R Chapman-Fredricks; Julie M Matthews; Offiong F Ikpatt; Phillip Ruiz; Izidore S Lossos
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

7.  A B-Cell Superantigen Induces the Apoptosis of Murine and Human Malignant B Cells.

Authors:  Daniela Lorenzo; Alejandra Duarte; Juliana Mundiñano; Paula Berguer; Irene Nepomnaschy; Isabel Piazzon
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

Review 8.  Superantigens and nasal polyps.

Authors:  Claus Bachert; Thibaut van Zele; Philippe Gevaert; Lore De Schrijver; Paul Van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919

9.  Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Jiun-Bo Chen; Louisa K James; Anna M Davies; Yu-Chang Bryan Wu; Joanne Rimmer; Valerie J Lund; Jou-Han Chen; James M McDonnell; Yih-Chih Chan; George H Hutchins; Tse Wen Chang; Brian J Sutton; Harsha H Kariyawasam; Hannah J Gould
Journal:  J Allergy Clin Immunol       Date:  2016-09-19       Impact factor: 10.793

10.  Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Kaibo Yang; Yanqiu Chen; Hanzhou Qi; Yiling Ye; Zhiping Fan; Fen Huang; Haiyan Zhang; Yuan Suo; Qifa Liu; Hua Jin
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.